INR 1693.5
(2.36%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 6.62 Billion INR | -1.14% |
2022 | 6.69 Billion INR | 19.18% |
2021 | 5.62 Billion INR | 36.76% |
2020 | 4.11 Billion INR | 6.32% |
2019 | 3.86 Billion INR | 29.1% |
2018 | 2.99 Billion INR | 22.7% |
2017 | 2.44 Billion INR | 14.64% |
2016 | 2.12 Billion INR | 18.26% |
2015 | 1.8 Billion INR | 12.19% |
2014 | 1.6 Billion INR | 12.82% |
2013 | 1.42 Billion INR | 14.97% |
2012 | 1.23 Billion INR | 29.63% |
2011 | 954.25 Million INR | 7.11% |
2010 | 890.87 Million INR | 10.0% |
2009 | 809.89 Million INR | 8.68% |
2008 | 745.19 Million INR | 8.56% |
2007 | 686.42 Million INR | 7.52% |
2006 | 638.38 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 6.69 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 6.62 Billion INR | -1.14% |
2023 Q4 | 6.62 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 6.83 Billion INR | 0.0% |
2022 Q2 | 6.23 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 6.69 Billion INR | 0.0% |
2022 FY | 6.69 Billion INR | 19.18% |
2022 Q1 | - INR | -100.0% |
2021 FY | 5.62 Billion INR | 36.76% |
2021 Q2 | 4.3 Billion INR | 0.0% |
2021 Q4 | 5.62 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 4.33 Billion INR | 0.0% |
2020 Q4 | 4.11 Billion INR | 0.0% |
2020 FY | 4.11 Billion INR | 6.32% |
2019 FY | 3.86 Billion INR | 29.1% |
2019 Q4 | 3.86 Billion INR | 0.0% |
2019 Q2 | 3.48 Billion INR | 0.0% |
2018 FY | 2.99 Billion INR | 22.7% |
2018 Q4 | 2.99 Billion INR | 0.0% |
2017 FY | 2.44 Billion INR | 14.64% |
2016 FY | 2.12 Billion INR | 18.26% |
2015 FY | 1.8 Billion INR | 12.19% |
2014 FY | 1.6 Billion INR | 12.82% |
2013 FY | 1.42 Billion INR | 14.97% |
2012 Q4 | 1.23 Billion INR | 0.0% |
2012 FY | 1.23 Billion INR | 29.63% |
2012 Q2 | 2 Billion INR | 0.0% |
2011 FY | 954.25 Million INR | 7.11% |
2010 FY | 890.87 Million INR | 10.0% |
2009 FY | 809.89 Million INR | 8.68% |
2008 FY | 745.19 Million INR | 8.56% |
2007 FY | 686.42 Million INR | 7.52% |
2006 FY | 638.38 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 89.724% |
Aurobindo Pharma Limited | 450.71 Billion INR | 98.53% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 76.763% |
Granules India Limited | 55.2 Billion INR | 88.003% |
Indoco Remedies Limited | 21.44 Billion INR | 69.117% |
Achyut Healthcare Limited | 309.52 Million INR | -2039.903% |
Ajanta Pharma Limited | 46.38 Billion INR | 85.72% |
Alkem Laboratories Limited | 155.74 Billion INR | 95.747% |
Alpa Laboratories Limited | 1.82 Billion INR | -262.688% |
Brooks Laboratories Limited | 904.45 Million INR | -632.317% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 38.559% |
Bajaj HealthCare Limited | 7.65 Billion INR | 13.433% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 45.435% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.291% |
Eris Lifesciences Limited | 70.48 Billion INR | 90.603% |
FDC Limited | 24.68 Billion INR | 73.164% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 95.387% |
Gufic Biosciences Limited | 10.92 Billion INR | 39.376% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 43.151% |
Ipca Laboratories Limited | 111.01 Billion INR | 94.034% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -205.119% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -271.74% |
Lasa Supergenerics Limited | 1.5 Billion INR | -339.022% |
Laurus Labs Limited | 83.87 Billion INR | 92.103% |
Lupin Limited | 239.97 Billion INR | 97.24% |
Mankind Pharma Limited | 119.63 Billion INR | 94.463% |
Medicamen Biotech Limited | 2.94 Billion INR | -124.888% |
Medico Remedies Limited | 961.95 Million INR | -588.544% |
Megasoft Limited | 3.65 Billion INR | -81.019% |
NATCO Pharma Limited | 69.06 Billion INR | 90.41% |
Piramal Pharma Limited | 153.11 Billion INR | 95.674% |
RPG Life Sciences Limited | 5.12 Billion INR | -29.145% |
Sigachi Industries Limited | 6.94 Billion INR | 4.582% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.225% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 70.616% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -63.678% |
Unichem Laboratories Limited | 31.69 Billion INR | 79.101% |
Wanbury Limited | 3.43 Billion INR | -92.827% |
Windlas Biotech Limited | 6.26 Billion INR | -5.771% |
ZIM Laboratories Limited | 4.46 Billion INR | -48.235% |
Zydus Lifesciences Limited | 292.8 Billion INR | 97.738% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -28.601% |
Divi's Laboratories Limited | 154.7 Billion INR | 95.719% |
Procter & Gamble Health Limited | 7.94 Billion INR | 16.619% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -80.54% |
Bal Pharma Limited | 3.2 Billion INR | -106.732% |
Strides Pharma Science Limited | 58.39 Billion INR | 88.658% |
Venus Remedies Limited | 6.26 Billion INR | -5.666% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 74.349% |
Nectar Lifesciences Limited | 21.91 Billion INR | 69.77% |
Shilpa Medicare Limited | 30.93 Billion INR | 78.587% |
Aarti Drugs Limited | 24.32 Billion INR | 72.769% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 70.489% |
Suven Life Sciences Limited | 2.84 Billion INR | -132.482% |
Ind-Swift Limited | 6.54 Billion INR | -1.203% |
Valiant Laboratories Limited | 3.42 Billion INR | -93.28% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 83.417% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 71.827% |
Themis Medicare Limited | 5.66 Billion INR | -16.936% |
Hikal Limited | 24.87 Billion INR | 73.369% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 95.602% |
Sequent Scientific Limited | 15.4 Billion INR | 57.001% |
Novartis India Limited | 9.24 Billion INR | 28.389% |
Wockhardt Limited | 76.49 Billion INR | 91.341% |
Jubilant Pharmova Limited | 115.48 Billion INR | 94.265% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1306.774% |
Neuland Laboratories Limited | 18.32 Billion INR | 63.857% |
Morepen Laboratories Limited | 12.93 Billion INR | 48.783% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -175.907% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -98.65% |